Web Results

www.geovax.com/investors.html

Recent entry into high-profile Zika vaccine space with multiple collaborators ... vaccine candidate for prevention of HIV infection in the developed world (HIV ...

www.geovax.com/the-need-for-an-hiv-aids-vaccine.html

The Need for an HIV/AIDS Vaccine. HIV/AIDS Facts. HIV/AIDS is the 5th leading cause of death globally; 34M people currently living with HIV (all clades) ...

www.geovax.com/overview-hiv-aids.html

Several AIDS-causing HIV-1 virus subtypes, or "clades", exist in different regions throughout the world. These subtypes are identified as subtype A, subtype B on ...

www.geovax.com/publications.html

The Immune Space: A Concept and Template for Rationalizing Vaccine ... by a repeated dose SIVsmE660 challenge despite different immune responses.

www.geovax.com/about-geovax.html

GeoVax Labs, Inc. (OTCBB: GOVX) is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using our ...

www.geovax.com/what-are-vaccines.html

This approach was employed to devise the first AIDS vaccine candidate tested in ... The difference is that the active ingredients are not the purified antigens ...

www.pharmavoice.com/article/2016-05-hiv

There has been remarkable progress made against HIV / AIDS, in which the disease ... a vaccine that would protect against the different subtypes of the disease. .... GeoVax is also researching this technology in the immune-oncology space for ...

www.sciencedirect.com/science/article/pii/S1045105615001360

Dec 28, 2015 ... Clinical development of prophylactic HIV/AIDS vaccines presents many ... Similarly, different types of immune mechanisms may play a role in protection .... Geovax Labs, Inc. (http://www.geovax.com/, accessed 10/14/2014, USA) has been ..... vaccines or regimens, i.e., filling a novel immunological “space,” ...

online.liebertpub.com/doi/full/10.1089/aid.2014.0040

Jun 26, 2014 ... 4International AIDS Vaccine Initiative, New York, New York. ... 10GeoVax Inc., Smyrna, Georgia. ... may not prove to be valid in other populations (with different host genetics, circulating HIV subtypes, prior antigenic exposures, ...

www.nyas.org/AIDS-eB

Jul 26, 2010 ... Harriet L. Robinson (GeoVax Inc.) Alan Bernstein (Global HIV Vaccine Enterprise ) Jerome Kim (Walter Reed Army Institute of Research) ...